Shedding light on hidradenitis suppurativa (HS)


Michelle Lowes, MB.BS, PhD

Associate Attending Physician, The Rockefeller University, Hidradenitis Suppurativa Foundation (HSF) Board Member

James Krueger, MD, PhD

D. Martin Carter Professor in Clinical Investigation, Director, Milstein Medical Research Program, Senior Attending Physician, Head, Laboratory of Investigative Dermatology, The Rockefeller University

Afsaneh Alavi, MD, MS

Associate Professor, Women’s College Hospital, University of Toronto, Canadian Hidradenitis Suppurativa Foundation (CHSF) Past President

Angela Parks-Miller, CCRP, CWCA

Clinical Research Manager for Investigator Initiated Studies, Department of Dermatology, Henry Ford Hospital, Detroit, MI, Hope for HS, President and Founding Director Hidradenitis Suppurativa Foundation (HSF), National Director of Advocacy and Support

Session Goals:

To educate HS patients and their families about HS, including the patient perspective

To update physicians regarding the frequency, diagnosis, and treatment options for HS

To share progress in HS care and research


Monday May 21, 2018; 6:00 PM to 8:00 PM ET


Shedding light on hidradenitis suppurativa (HS) (PDF)


Recent Webcasts

Prescription Pain Medication Use in the Community

Linda B. Cottler, PhD, MPH, FACE, Associate Dean for Research, College of Public Health and Health Professions and Dean's Professor of Epidemiology at the University of Florida